Therapeutics MD

    0
    41
    RSS Source: https://www.therapeuticsmd.com/
    Default Action: directlink
    Default Link Follow: nofollow
    Default Link Target: newtab
    Affiliate Code:
    Ad-hoc links are allowed for this source.
    Feed Title: TherapeuticsMD Inc News Releases
    - TherapeuticsMD Inc News Releases

    - Quarterly total net product revenue of $24.5 million , an increase of 41.1% over Q3 2020 - - ANNOVERA ® TRx of 8,351, an increase of 62.7% over Q3 2020 - - Cost savings initiative to reduce SG&A by $40 million in 2022; anticipated additional savings of approximately $20 million annualized tied to

    - TherapeuticsMD Inc News Releases

    - Mr. O’Dowd to succeed Robert G. Finizio , effective on or before December 31, 2021 - - Mr. Finizio appointed Vice Chair of the Board - BOCA RATON, Fla. --(BUSINESS WIRE)--Nov. 11, 2021-- TherapeuticsMD, Inc. (NASDAQ: TXMD) (TXMD or the Company), an innovative, leading women’s healthcare company,

    - TherapeuticsMD Inc News Releases

    -Executive Management to Host Conference Call on November 11, 2021 at 8:30 a.m. ET - BOCA RATON, Fla. --(BUSINESS WIRE)--Oct. 27, 2021-- TherapeuticsMD, Inc. (NASDAQ: TXMD) (“TXMD” or the “Company”), an innovative, leading women’s healthcare company, today announced that it will report its third

    - TherapeuticsMD Inc News Releases

    BOCA RATON, Fla. --(BUSINESS WIRE)--Oct. 15, 2021-- TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative, leading women’s healthcare company, today announced the appointment of Mark Glickman as the Company’s Chief Business Officer. Mr. Glickman previously served as Chief Commercial Officer of

    - TherapeuticsMD Inc News Releases

    September is Menopause Awareness month, and TherapeuticsMD aims to de-stigmatize and provide education every woman should know about menopause In the next ten years, there will be more than 1.2 billion women worldwide in menopause i More than 80% of women experience some symptoms around menopause i

    - TherapeuticsMD Inc News Releases

    CMS has established new HCPCS Level II code J7294 to be effective October 1 st , 2021 J Code will provide dispensing Title X Family Planning clinics such as Planned Parenthood facilities with the ability to get reimbursed for dispensing ANNOVERA BOCA RATON, Fla. --(BUSINESS WIRE)--Aug.

    - TherapeuticsMD Inc News Releases

    – O’Dowd brings 25+ years of experience in senior leadership roles with leading pharmaceutical companies – BOCA RATON, Fla. --(BUSINESS WIRE)--Aug. 9, 2021-- TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative, leading women’s healthcare company, today announced the appointment of Hugh O’Dowd as

    - TherapeuticsMD Inc News Releases

    - 2Q21 total net product revenue increased by 17% over 1Q21 to $23 million - - ANNOVERA ® prescription growth supported by improved access to providers and increased telemedicine options for patients - - Prescriptions for IMVEXXY® grew by 8% over 1Q21, outpacing the VVA market - - Centers for

    - TherapeuticsMD Inc News Releases

    -Executive Management to Host Conference Call on August 4, 2021 at 8:30 a.m. ET - BOCA RATON, Fla. --(BUSINESS WIRE)--Jul. 26, 2021-- TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative, leading women’s healthcare company, today announced that it will report its second quarter 2021 financial results

    - TherapeuticsMD Inc News Releases

    BOCA RATON, Fla. --(BUSINESS WIRE)--May 25, 2021-- TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative, leading women’s healthcare company, announced today that the Company submitted a supplemental New Drug Application (“sNDA”) for BIJUVA (estradiol and progesterone) capsules, 0.5 mg/100 mg, to the

    LEAVE A REPLY

    Please enter your comment!
    Please enter your name here